This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, particularly as a key building block for compounds with potential antidepressant or anxiolytic properties. Its chiral structure allows for the creation of enantiomerically pure substances, enhancing the efficacy and reducing side effects of the final drug product. Additionally, it is employed in research settings for the study of receptor binding and neurotransmitter modulation, aiding in the discovery of novel therapeutic agents.